News + Filings Holdings
|
ROYCE & ASSOCIATES LP
> SUPN
| Date | Name | Ticker | Shares | Change | Value | Change | Price |
| 06/30/2023 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | 0 | -43,619 | 0 | -1,580,316,000 | |
| 03/31/2023 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | 43,619 | -1,272 | 1,580,316,000 | 1,579,018,000 | $36,229.99 |
| 06/30/2022 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | 44,891 | -8,919 | 1,298,000 | -441,000 | $28.91 |
| 03/31/2022 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | 53,810 | -204,314 | 1,739,000 | -5,788,000 | $32.32 |
| 12/31/2021 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | 258,124 | -113,201 | 7,527,000 | -2,376,000 | $29.16 |
| 09/30/2021 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | 371,325 | 4,430 | 9,903,000 | -1,394,000 | $26.67 |
| 06/30/2021 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | 366,895 | -9,504 | 11,297,000 | 1,443,000 | $30.79 |
| 03/31/2021 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | 376,399 | -10,832 | 9,854,000 | 111,000 | $26.18 |
| 12/31/2020 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | 387,231 | 89,053 | 9,743,000 | 3,529,000 | $25.16 |
| 09/30/2020 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | 298,178 | 51,149 | 6,214,000 | 347,000 | $20.84 |
| 06/30/2020 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | 247,029 | 14,027 | 5,867,000 | 1,675,000 | $23.75 |
| 03/31/2020 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | 233,002 | -16,500 | 4,192,000 | -1,726,000 | $17.99 |
| 12/31/2019 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | 249,502 | 32,093 | 5,918,000 | -56,000 | $23.72 |
| 09/30/2019 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | 217,409 | 203,189 | 5,974,000 | 5,503,000 | $27.48 |
| 06/30/2019 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | 14,220 | 6,318 | 471,000 | 194,000 | $33.12 |
| 03/31/2019 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | 7,902 | 7,902 | 277,000 | 277,000 | $35.05 |
| 09/30/2018 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | 0 | -58,000 | 0 | -3,471,000 | |
| 06/30/2018 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | 58,000 | -9,000 | 3,471,000 | 402,000 | $59.84 |
| 03/31/2018 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | 67,000 | -32,000 | 3,069,000 | -876,000 | $45.81 |
| 12/31/2017 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | 99,000 | -60,000 | 3,945,000 | -2,415,000 | $39.85 |
| 09/30/2017 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | 159,000 | 0 | 6,360,000 | -493,000 | $40.00 |
| 06/30/2017 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | 159,000 | 29,000 | 6,853,000 | 2,784,000 | $43.10 |
| 03/31/2017 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | 130,000 | 130,000 | 4,069,000 | 4,069,000 | $31.30 |
| << Prev Next >> |
|